The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Gene Synthesis Subcloning Service Market Research Report 2025

Global Gene Synthesis Subcloning Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1909849

No of Pages : 96

Synopsis
The global Gene Synthesis Subcloning Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gene Synthesis Subcloning Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Synthesis Subcloning Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Synthesis Subcloning Service in Academic and Research Institutions is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Synthesis Subcloning Service include Thermo Fisher Scientific, Eurofins Scientific, Merck KGaA, Genscript Biotech Corp, Synbio Technologies, Bio Basic, Bioneer Corporation, Applied Biological Materials and Takara Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Synthesis Subcloning Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Synthesis Subcloning Service.
Report Scope
The Gene Synthesis Subcloning Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Synthesis Subcloning Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Synthesis Subcloning Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Eurofins Scientific
Merck KGaA
Genscript Biotech Corp
Synbio Technologies
Bio Basic
Bioneer Corporation
Applied Biological Materials
Takara Bio
Canvax Biotech
Codex DNA
Azenta US
Macrogen
InvivoGen
BioCat GmbH
BEX Co., Ltd
Lonza Group
Segment by Type
Stranded Gene
Complex Gene
Others
Segment by Application
Academic and Research Institutions
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Synthesis Subcloning Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Synthesis Subcloning Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stranded Gene
1.2.3 Complex Gene
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gene Synthesis Subcloning Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic and Research Institutions
1.3.3 Clinical Laboratories
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Synthesis Subcloning Service Market Perspective (2019-2030)
2.2 Gene Synthesis Subcloning Service Growth Trends by Region
2.2.1 Global Gene Synthesis Subcloning Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Synthesis Subcloning Service Historic Market Size by Region (2019-2024)
2.2.3 Gene Synthesis Subcloning Service Forecasted Market Size by Region (2025-2030)
2.3 Gene Synthesis Subcloning Service Market Dynamics
2.3.1 Gene Synthesis Subcloning Service Industry Trends
2.3.2 Gene Synthesis Subcloning Service Market Drivers
2.3.3 Gene Synthesis Subcloning Service Market Challenges
2.3.4 Gene Synthesis Subcloning Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Synthesis Subcloning Service Players by Revenue
3.1.1 Global Top Gene Synthesis Subcloning Service Players by Revenue (2019-2024)
3.1.2 Global Gene Synthesis Subcloning Service Revenue Market Share by Players (2019-2024)
3.2 Global Gene Synthesis Subcloning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Synthesis Subcloning Service Revenue
3.4 Global Gene Synthesis Subcloning Service Market Concentration Ratio
3.4.1 Global Gene Synthesis Subcloning Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Synthesis Subcloning Service Revenue in 2023
3.5 Gene Synthesis Subcloning Service Key Players Head office and Area Served
3.6 Key Players Gene Synthesis Subcloning Service Product Solution and Service
3.7 Date of Enter into Gene Synthesis Subcloning Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Synthesis Subcloning Service Breakdown Data by Type
4.1 Global Gene Synthesis Subcloning Service Historic Market Size by Type (2019-2024)
4.2 Global Gene Synthesis Subcloning Service Forecasted Market Size by Type (2025-2030)
5 Gene Synthesis Subcloning Service Breakdown Data by Application
5.1 Global Gene Synthesis Subcloning Service Historic Market Size by Application (2019-2024)
5.2 Global Gene Synthesis Subcloning Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Synthesis Subcloning Service Market Size (2019-2030)
6.2 North America Gene Synthesis Subcloning Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Synthesis Subcloning Service Market Size by Country (2019-2024)
6.4 North America Gene Synthesis Subcloning Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Synthesis Subcloning Service Market Size (2019-2030)
7.2 Europe Gene Synthesis Subcloning Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Synthesis Subcloning Service Market Size by Country (2019-2024)
7.4 Europe Gene Synthesis Subcloning Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Synthesis Subcloning Service Market Size (2019-2030)
8.2 Asia-Pacific Gene Synthesis Subcloning Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Synthesis Subcloning Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Synthesis Subcloning Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Synthesis Subcloning Service Market Size (2019-2030)
9.2 Latin America Gene Synthesis Subcloning Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Synthesis Subcloning Service Market Size by Country (2019-2024)
9.4 Latin America Gene Synthesis Subcloning Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Synthesis Subcloning Service Market Size (2019-2030)
10.2 Middle East & Africa Gene Synthesis Subcloning Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Synthesis Subcloning Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Synthesis Subcloning Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Synthesis Subcloning Service Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Gene Synthesis Subcloning Service Introduction
11.2.4 Eurofins Scientific Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.2.5 Eurofins Scientific Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Gene Synthesis Subcloning Service Introduction
11.3.4 Merck KGaA Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 Genscript Biotech Corp
11.4.1 Genscript Biotech Corp Company Detail
11.4.2 Genscript Biotech Corp Business Overview
11.4.3 Genscript Biotech Corp Gene Synthesis Subcloning Service Introduction
11.4.4 Genscript Biotech Corp Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.4.5 Genscript Biotech Corp Recent Development
11.5 Synbio Technologies
11.5.1 Synbio Technologies Company Detail
11.5.2 Synbio Technologies Business Overview
11.5.3 Synbio Technologies Gene Synthesis Subcloning Service Introduction
11.5.4 Synbio Technologies Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.5.5 Synbio Technologies Recent Development
11.6 Bio Basic
11.6.1 Bio Basic Company Detail
11.6.2 Bio Basic Business Overview
11.6.3 Bio Basic Gene Synthesis Subcloning Service Introduction
11.6.4 Bio Basic Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.6.5 Bio Basic Recent Development
11.7 Bioneer Corporation
11.7.1 Bioneer Corporation Company Detail
11.7.2 Bioneer Corporation Business Overview
11.7.3 Bioneer Corporation Gene Synthesis Subcloning Service Introduction
11.7.4 Bioneer Corporation Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.7.5 Bioneer Corporation Recent Development
11.8 Applied Biological Materials
11.8.1 Applied Biological Materials Company Detail
11.8.2 Applied Biological Materials Business Overview
11.8.3 Applied Biological Materials Gene Synthesis Subcloning Service Introduction
11.8.4 Applied Biological Materials Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.8.5 Applied Biological Materials Recent Development
11.9 Takara Bio
11.9.1 Takara Bio Company Detail
11.9.2 Takara Bio Business Overview
11.9.3 Takara Bio Gene Synthesis Subcloning Service Introduction
11.9.4 Takara Bio Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.9.5 Takara Bio Recent Development
11.10 Canvax Biotech
11.10.1 Canvax Biotech Company Detail
11.10.2 Canvax Biotech Business Overview
11.10.3 Canvax Biotech Gene Synthesis Subcloning Service Introduction
11.10.4 Canvax Biotech Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.10.5 Canvax Biotech Recent Development
11.11 Codex DNA
11.11.1 Codex DNA Company Detail
11.11.2 Codex DNA Business Overview
11.11.3 Codex DNA Gene Synthesis Subcloning Service Introduction
11.11.4 Codex DNA Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.11.5 Codex DNA Recent Development
11.12 Azenta US
11.12.1 Azenta US Company Detail
11.12.2 Azenta US Business Overview
11.12.3 Azenta US Gene Synthesis Subcloning Service Introduction
11.12.4 Azenta US Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.12.5 Azenta US Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Detail
11.13.2 Macrogen Business Overview
11.13.3 Macrogen Gene Synthesis Subcloning Service Introduction
11.13.4 Macrogen Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.13.5 Macrogen Recent Development
11.14 InvivoGen
11.14.1 InvivoGen Company Detail
11.14.2 InvivoGen Business Overview
11.14.3 InvivoGen Gene Synthesis Subcloning Service Introduction
11.14.4 InvivoGen Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.14.5 InvivoGen Recent Development
11.15 BioCat GmbH
11.15.1 BioCat GmbH Company Detail
11.15.2 BioCat GmbH Business Overview
11.15.3 BioCat GmbH Gene Synthesis Subcloning Service Introduction
11.15.4 BioCat GmbH Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.15.5 BioCat GmbH Recent Development
11.16 BEX Co., Ltd
11.16.1 BEX Co., Ltd Company Detail
11.16.2 BEX Co., Ltd Business Overview
11.16.3 BEX Co., Ltd Gene Synthesis Subcloning Service Introduction
11.16.4 BEX Co., Ltd Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.16.5 BEX Co., Ltd Recent Development
11.17 Lonza Group
11.17.1 Lonza Group Company Detail
11.17.2 Lonza Group Business Overview
11.17.3 Lonza Group Gene Synthesis Subcloning Service Introduction
11.17.4 Lonza Group Revenue in Gene Synthesis Subcloning Service Business (2019-2024)
11.17.5 Lonza Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’